Aeterna Zentaris, in collaboration with the University of Sheffield, in the U.K., selected AEZS-150 as its lead candidate for…
Articles by Marta Figueiredo, PhD
People who develop chronic hypoparathyroidism following surgery to remove the thyroid gland have significantly poorer quality of life than those…
A single dose of AZP-3601 — Amolyt Pharma’s experimental therapy for hypoparathyroidism — resulted in a significant, sustained…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AZP-3601, an investigational therapy for hypoparathyroidism by…
Immune checkpoint inhibitors (ICIs), a type of immune therapy used to treat some cancers, may lead to the development of…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…
Having a greater than 65% drop in parathyroid hormone (PTH) levels on the first day after a total thyroid…
The International Osteoporosis Foundation (IOF) recently launched Skeletal Rare Diseases Academy, recognizing two researchers with awards for their…
People with hypoparathyrodism have significantly higher blood pressure and stiffness of blood arteries — two known risk factors for…